Denemek ALTIN - Özgür
The uncertain comfort on prices
Business Standard
|November 13, 2025
Inflation could stay low for some time, but should be viewed with caution amid global risks and climate change
A sharp slide in consumer inflation has been the most encouraging news for the Indian economy this year. And, going by history, this phase can continue for some time.
Inflation based on the Consumer Price Index (CPI) has been below 4 per cent in the past nine months, averaging 2.3 percent. It reached 0.25 percent in October, the lowest print in current CPI series, and below the Reserve Bank of India’s target range of 2 to 6 percent.
To be sure, there have been such episodes earlier, when average inflation was lower than 4 per cent. The longest was between fiscals 2000 and 2005, when CPI inflation averaged 3.9 per cent. The next was between fiscals 2018 and 2019, when inflation averaged 3.5 per cent. These episodes were accompanied by sustained drop in food inflation.
Yet, the gathering dark clouds of geopolitical uncertainty and climate change events seems to warrant a cautious view. The factors are telltale.
What decides how long inflation stays low?
Food, the main driver
All episodes of low headline inflation followed a sharp fall in food inflation, which has a 39 per cent weight in the current inflation basket. Food inflation was much lower than nonfood between fiscals 2000 and 2005 (2.2 percent versus 5.5 percent), and fiscals 2018 and 2019 (1 per cent versus 5.2 percent).
In the current fiscal, too, the decline in inflation was led by food (minus 1.1 percent in fiscal 2026 so far versus 7.3 percent in fiscal 2025).
Vegetables, pulses and cereals drove the decline in food inflation this fiscal. Among these, vegetable inflation is highly volatile, with large swings often creating statistical distortions. Average retail vegetable inflation, at minus 18.4 per cent this fiscal, is partly driven by a high base of 20 per cent in the last fiscal. CPI inflation excluding fruits and vegetables has been slightly higher (3.4 percent).
Bu hikaye Business Standard dergisinin November 13, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Business Standard'den DAHA FAZLA HİKAYE
Business Standard
Labour Codes impact: HCL tech profit slips 11%
Q3 top line beats Street estimates, bottom line misses expectations
2 mins
January 13, 2026
Business Standard
New labour Codes, restructuring weigh on TCS earnings
Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.
1 min
January 13, 2026
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS
Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Listen
Translate
Change font size
